MIRA
INFORM REPORT
|
Report Date : |
11.10.2007 |
IDENTIFICATION DETAILS
|
Name : |
VALDEQUÍMICA PRODUTOS QUÍMICOS LTDA. |
|
|
|
|
Registered Office : |
Rua dos Três Irmãos, 212 – Caxingui, 05615-190 – |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
July 18, 1972 |
|
|
|
|
Com. Reg. No.: |
35.201.209.861 |
|
|
|
|
Legal Form : |
Private Limited Company Joint Stock |
|
|
|
|
Line of Business : |
Wholesale trade of pharmaceutical
products, perfumery, cosmetics. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Company name
VALDEQUÍMICA PRODUTOS QUÍMICOS LTDA.
Trade Name
VALDEQUÍMICA
Address
Rua dos Três Irmãos, 212 – Caxingui
05615-190 –
Phone: (55-11)
3721 6407 / 1391 / 2512 / 5067
E-mail: (55-11)
3721 6376
E-mail: valdepq@uol.com.br
Web Site: www.valdequimica.com.br
Legal information
Legal Status: Private Limited Company Joint Stock
Incorporation date: July 18, 1972
Register number #: 35.201.209.861
Tax contributor (CNPJ): 43.365.816/0001-21
Registered Capital: R$2.500.000,00
State Registration #: 108.802.143.113
Number of employees: 37
Branches: 01
History
Established on July 18, 1972, chartered at the State Commerce Registration Office of São Paulo (JUCESP) under # 35.201.209.861 into the present registered name.
Partnership/Management:
Paulo Aparecido Perez Martins (02/1977) - 50,0%
Brazilian,
CPF: 515.987.448-87
Albano José Pereira dos
Portuguese, CPF: 295.794.908-30
Properties
Immobile on behalf of the company in the value of R$100.000,00.
Immobile on behalf of the partner Paulo Aparecido Perez Martins in the value
of R$300.000,00
Registered
line of business:
Wholesale trade of pharmaceutical products,
perfumery, cosmetics.
Main Products:
90% - Analgesic
10% - Antibiotics
Import
countries:
Not informed.
Export
countries:
Not informed.
Purchases:
20% - Domestic market
80% - International market
Sales:
100% - Domestic market
Related Companies
Stock participation:
OVER FRANCHISING ADM. E PARTICIPAÇÕES - CNPJ:07.919.691/0001-70
- Paulo Aparecido Perez Martins - 50,0%
Financial Data
According to the Brazilian Law Private Limited Companies are not obliged to file financial accounts for public inspection.
Quarterly balance sheet as of 30/06/2007 –
US$1.00 = R$1,926
Balance sheet information for fiscal year
ending:
31/12/2006 – US$1.00 = R$2,138
31/12/2005 – US$1.00 = R$2,341
Figures are in (Thousands of) Reais R$:
Assets
|
06/2007 |
2006 |
2005 |
|
Current Assets |
6.894 |
7.607 |
7.583 |
|
Inventory |
2.627 |
3.312 |
4.261 |
Other Assets
|
4.267 |
4.295 |
3.322 |
Long Term Assets
|
92 |
0 |
0 |
Fixed
Assets
|
768 |
792 |
633 |
Investment
|
3 |
3 |
3 |
|
Immovable |
765 |
789 |
630 |
Total
Assets
|
7.754 |
8.399 |
8.216 |
Liabilities
|
06/2007 |
2006 |
2005 |
Current
Liabilities
|
4.311 |
4.712 |
3.966 |
|
Suppliers |
595 |
498 |
391 |
Other liabilities
|
3.716 |
4.214 |
3.575 |
Net Equity
|
3.443 |
3.687 |
4.250 |
Capital
|
2.500 |
2.500 |
2.500 |
Accumulated Profit (Loss)
|
943 |
1.187 |
1.750 |
Total
Liabilities
|
7.754 |
8.399 |
8.216 |
Income Statement
|
06/2007 |
2006 |
2005 |
Annual Net
Sales
|
8.265 |
18.682 |
16.629 |
Gross
Income
|
2.131 |
4.975 |
4.425 |
Operating
Income
|
193 |
785 |
653 |
Net Income
|
135 |
519 |
86 |
Financial Analysis
|
06/2007 |
2006 |
2005 |
Current Ratio
|
1,59 |
1,61 |
1,91 |
Current Debt Ratio
|
1,25 |
1,27 |
1,07 |
Total Debt Ratio
|
2,25 |
2,27 |
1,93 |
Working Capital
|
$2.583 |
$2.895 |
$3.617 |
(Dollar rate US$1.00 = R$1,811 on 09/10/2007).
Banking
Banco Bradesco S/A. -
branch - 2199
Banco do Brasil S/A. -
branch - 3336
Banco Itaubank S/A. -
branch - 0053
Remark:
banking
comments could not be obtained due to legal restrictions from the Brazilian
Law.
No returned checks were found either in the name of the company or partners.
Insurance
Not informed.
Payment information
*Information obtained from outside sources
and public consulted.
154 – Invoices:
Information on purchases:
SEP//2007 Last: R$36.375 Average: R$4.451
Information on invoicing:
SEP//2007 Highest: R$36.375 Average: R$6.497
Information on accumulation:
SEP//2007 Highest: R$53.562 Average: R$11.859
99% - Prompt payments
01% - Delays from 08 up to 15 days
Trade References
Main
Suppliers:
Catalent Brasil Ltda.
Degussa Brasil Ltda.
Ab Farmo Indústria Farmaceutica Ltda.
Denver Cotia Indústria e Comércio de
Produtos Químicos Ltda.
Main
clients:
Belfar Ltda.
Hipolabor Farmaceutica Ltda.
Royton Química Farmaceutica Ltda.
Ciofarma Cientifica Farmaceutica Ltda.
Public Records
Information
No negative information was found.
Remarks
The information in this report were obtained from outside sources and public records consulted.
Final Opinion
We believe it may be possible to have trade relation with the subject
company with amounts that fit to its economic-financial resources, under usual
terms.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)